Form D · Pharmaceuticals

Collidion Inc.

Petaluma, CA · CIK 0001668476

Offering snapshot reported Oct 31, 2019 · SEC filing

Reported sold
$14.3M
Offering amount: $15M
Investors reported
147
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Feb 12, 2016
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$7.13M$14.3MMar 2, 2016: $300,000.00Mar 2, 2016Jan 4, 2017: $1,445,000.00Jan 4, 2017Jan 10, 2018: $9,953,000.00Jan 10, 2018Mar 19, 2019: $11,643,750.00Jul 3, 2019: $13,153,750.00Oct 31, 2019: $14,255,000.00Oct 31, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$13,153,750 → $14,255,000
  • Reported investors139 → 147

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 31, 2019Amendment$14,255,000$1,101,250vs Jul 3, 2019147SEC filing
Aug 8, 2019Initial$275,000No comparison3SEC filing
Jul 3, 2019Amendment$13,153,750$1,510,000vs Mar 19, 2019139SEC filing
Mar 19, 2019Amendment$11,643,750$1,690,750vs Jan 10, 2018123SEC filing
Jan 10, 2018Amendment$9,953,000$8,508,000vs Jan 4, 201798SEC filing
Jan 4, 2017Amendment$1,445,000$1,145,000vs Mar 2, 201617SEC filing
Mar 2, 2016Initial$300,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06c
Duration over one year
Yes
Business combination
No
Sales commissions
$147K (estimated)
Finders' fees
$0
Form D file number
021-258434

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Guy B Crawford864093R.F. Lafferty & Co., Inc. · CRD 2498

Source: Form D, filed Oct 31, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Hojabr Alimi Director, Executive
Gregg Alton Director
Ettore M. Carino Director
Jeffrey Castillo Director
Mark Fenlon Director
Gregory French Director
Sameer Harish Executive
Elliot Maza Executive
William H. Watson Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1770 Corporate Circle
Petaluma, CA, 94954